|1.||Kirim, Rukaiyatu Abdullahi: 1 article (03/2015)|
|2.||Masimirembwa, Collen: 1 article (03/2015)|
|3.||Mustapha, Kudirat Bola: 1 article (03/2015)|
|4.||Thelingwani, Roslyn: 1 article (03/2015)|
|5.||Gamaniel, Karniyus Shingu: 1 article (03/2015)|
|6.||Adzu, Bulus: 1 article (03/2015)|
|7.||Oniyangi, Oluseyi: 1 article (01/2015)|
|8.||Cohall, Damian H: 1 article (01/2015)|
|9.||Inyang, Uford S: 1 article (03/2010)|
|10.||Oyedele, Eunice O: 1 article (03/2010)|
|1.||Sickle Cell Anemia (Hemoglobin S Disease)
01/01/2015 - "The Phase IIB (pivotal) trial suggests that Niprisan(®) was effective in reducing episodes of severe painful sickle cell disease crisis over a six-month period. "
01/01/2015 - "While Niprisan(®) appeared to be safe and effective in reducing severe painful crises over a six-month follow-up period, further trials are required to assess its role in the management of people with sickle cell disease and the results of its multicentre trials are awaited. "
07/01/2001 - "The study was undertaken to determine the safety and efficacy of NIPRISAN, a phytomedicine, developed for the management of patients with Sickle Cell Disorder (SCD). "
01/01/2015 - "Based on the published results for Niprisan(®) and in view of the limitations in data collection and analysis of both trials, phytomedicines may have a potential beneficial effect in reducing painful crises in sickle cell disease. "
03/01/2010 - "A normative study of the components of niprisan--an herbal medicine for sickle cell anemia."
01/01/2004 - "This Phase IIB (pivotal) study suggests that a phytomedicine, NIPRISAN, was effective in reducing episodes of SCD crisis associated with severe pain over a six-month period. "
01/01/2004 - "While NIPRISAN, as a phytomedicine, appeared to be safe and effective, over a six-month follow-up period of this study, in reducing crises associated with severe pain, further studies are required to assess its role in the management of people with sickle cell disease. "
|1.||tranilast (N 5')